Research Articles | Page 3 | Aplastic Anemia & MDS International Foundation

Research Articles

Compiled for your convenience are articles on bone marrow failure research and treatment from the world’s major journals on hematology / oncology.

Article Title Original Publication Date Journal Bone Marrow Disease
A Meta-Analysis of the Relationship between Cigarette Smoking and Incidence of Myelodysplastic Syndromes. Jun 2013 PLoS One myelodysplastic syndromes (MDS)
A multivariate analysis of the relationship between response and survival among patients with higher-risk myelodysplastic syndromes treated within azacitidine or conventional care regimens in the randomized AZA-001 trial. Apr 2013 Haematologica myelodysplastic syndromes (MDS)
A novel clofarabine bridge strategy facilitates allogeneic transplantation in patients with relapsed/refractory leukemia and high-risk myelodysplastic syndromes. Jun 2013 Bone Marrow Transplant myelodysplastic syndromes (MDS)
A novel histone deacetylase inhibitor Chidamide induces G0/G1 arrest and apoptosis in myelodysplastic syndromes Oct 2016 Biomed Pharmacother myelodysplastic syndromes (MDS)
A novel marker for screening paroxysmal nocturnal hemoglobinuria using routine complete blood count and cell population data Jan 2015 Ann Lab Med paroxysmal nocturnal hemoglobinuria (PNH)
A Personalized Prediction Model for Outcomes after Allogeneic Hematopoietic Cell Transplant in Patients with Myelodysplastic Syndromes Aug 2020 Biology of blood and marrow transplantation: journal of the American Society for Blood and Marrow Transplantation myelodysplastic syndromes (MDS)
A Phase 1 Study of Oral ARRY-614, a p38 MAPK/Tie2 Dual Inhibitor, in Patients with Low or Intermediate 1 Risk Myelodysplastic Syndromes Dec 2014 Clin Cancer Res myelodysplastic syndromes (MDS)
A phase 2 trial of high dose lenalidomide in patients with relapsed/refractory higher-risk myelodysplastic syndromes and acute myeloid leukaemia with trilineage dysplasia Oct 2016 Br J Haematol myelodysplastic syndromes (MDS)
A phase 2 trial of the oral smoothened inhibitor glasdegib in refractory myelodysplastic syndromes (MDS) Mar 2019 Leukemia Research myelodysplastic syndromes (MDS)
A phase 3 randomized placebo-controlled trial of darbepoetin alfa in patients with anemia and lower-risk myelodysplastic syndromes Jun 2017 Leukemia myelodysplastic syndromes (MDS)